Abstract. We have examined the role of ms-related rab proteins in transport from the ER to the Golgi complex in vivo using a vaccinia recombinant T7 RNA polymerase virus to express site-directed rab mutants. These mutations are within highly conserved domains involved in guanine nucleotide binding and hydrolysis found in ras and all members of the ras superfamily. Substitutions in the GTP-binding domains of rabla and rablb (equivalent to the ras 17N and 116I mutants) resulted in proteins which were potent trans dominant inhibitors of vesicular stomatitis virus glycoprotein (VSV-G protein) transport between the ER and cis Golgi complex. Immunofluorescence analysis indicated that expression of rablbl:u prevented delivery of VSV-G protein to the Golgi stack, which resulted in VSV-G protein accumulation in pre-Golgi punctate structures. Mutants in guanine nucleotide exchange or hydrolysis of the rab2 protein were also strong trans dominant transport inhibitors. Analogous mutations in rab3a, rab5, rab6, and H-ras did not inhibit processing of VSV-G to the complex, sialic acid containing form diagnostic of transport to the trans Golgi compartment. We suggest that at least three members of the rab family (rabla, rablb, and rab2) use GTP hydrolysis to regulate components of the transport machinery involved in vesicle traffic between early compartments of the secretory pathway.
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M
EMBERS of the rab family of ms-related small GTPbinding proteins are associated with subcellular compartments in both the endocytic and exocytic pathways (reviewed in Balch, 1990; Goud and McCaffrey, 1991) . These proteins are likely to be key regulatory components of protein complexes catalyzing the fission and fusion of transport vesicles between distinct subcellular compartments. In support of their proposed function, the rab-related yeast GTP-binding proteins YPTI and SEC4 have been shown to be required for transport between the ER and the Golgi complex (reviewed in Hicke and Schekman, 1990; Schmitt et al., 1988; Segev et al., 1988; Bacon et al., 1989; Baker et al., 1990; Kaiser and Schekman, 1990) , and from the Golgi complex to the cell surface (Salminen and Novick, 1987; Goud et al., 1988; Walworth et al., 1989) , respectively. In addition, in vitro assays which efficiently reconstitute ER to Golgi ~kers et al., 1987) and intra-Golgi transport (reviewed in Waters et al., 1991; Rothman and Orci, 1992) are sensitive to the nonhydrolyzable analog of GTP, GTP3,S (Melancon et al., 1987; Beckers and Balch, 1989) .
Within the mammalian rab gene family, rabla and rablb share 70-80% identity to YPT1 (Valencia et al., 1991) . In fact, mouse rabla can complement mutant yeast which lack YPT1 (Haubruck et al., 1989) . Although genetic studies in yeast have shown that the YPT1 gene is required in vesicular transport, there is limited data which demonstrates a similar role of the mammalian rabl homologue in membrane traffic. We have shown that a peptide homologous to the putative effector domain of the rabl protein inhibits ER to Golgi transport, presumably by competition for a downstream effector molecule(s) required for vesicle fusion (Plutner et al., 1990) . In addition, a neutralizing monoclonal antibody specific for the rablb protein inhibits transport from the ER to the Golgi complex in vitro (Plutner et al., 1991) .
All members of the ras superfamily contain highly conserved domains required for guanine nucleotide binding, GTP/GDP 1 exchange, and GTP hydrolysis (Bourne et al., 1990; Bourne et al., 1991) . These domains interact with proteins which stimulate guanine nucleotide dissociation (GDS), inhibit GDP exchange (GDI), and promote GTP hydrolysis (GAP) (reviewed in Hall, 1990; Haubruck and McCormick, 1991; Wittinghofer and Pai, 1991; Takai et al., 1992) . A host of amino acid substitutions (>100) made in the ras GTP-binding and effector domains have led to the identification of several activation and inhibitory mutations (Barbacid, 1987) . Similar substitutions in the SEC4 and YPT1 proteins result in trans dominant negative phenotypes which inhibit vesicular transport (Walworth et al., 1989; Becker et al., 1991) .
Using the mutational analysis performed on ras as a model, we have explored the role of rab proteins in ER to Golgi complex transport in mammalian cells using sitedirected mutagenesis and a vaccinia based transient expression system. We report that rabla and rablb mutants with altered GDP/GTP binding properties behave as potent trans dominant inhibitors of ER to Golgi complex transport in vivo. In addition, we provide evidence that mutations in the GTP-binding domains of rab2, a small GTP-binding protein localized to a post-ER, pre-Golgi intermediate compartment (Chavrier et al., 1990a) , results in proteins which act as trans dominant inhibitors in vesicular traffic. Our results suggest that at least three members of the rab family (rabla, lb, and 2) are critical for regulating the biochemical machinery involved in vesicle fission and fusion between early compartments of the secretory pathway.
Materials and Methods

Cell Culture and Generation of Mutant Constructs
HeLa cells were cultured in DME (Gibco BRL, Grand Island, NY) supplemented with 10% FBS and penicillin-streptomycin in a 5% humidified CO2 incubator. Rab expression constructs were generated from canine rabla (Chavrier et al., 1990a) , rat rablb (Touchot et al., 1987) , and human rab2, rab3a, tab5, and rab6 (Zahraoui et al., 1989) eDNA sequences that have been generously provided by M. Zerial (EMBL, Heidelberg, Germany) and A. Tavitian (INSERM, Paris, France). All tab sequences were introduced into the Ndel and BamH1 sites of the pET3a vector (Novagen, Madison, WI) for expression (Studier et ai., 1990 ) from the T7 promoter as described previously (Khosravi-Far et al., 1991) . To generate structural mutants of each tab protein (see Table 2 ), oligonucleotide-directed mutagenesis was done on M13 mpl8 vector constructs of each rab eDNA sequence using the Polymerase HI Mutator protocol (Stratagene Corp., La Jolla, CA) or by Taql polymerase chain reaction DNA amplification. All mutated tab sequences were verified by dideoxy sequencing. The pET-tab constructs were introduced into E. coli strain BL21-DE3 (Novngen) for expression of recombinant tab protein and used for transfection experiments. The pAR-G (pET3a) plasmids encoding VSV-G and tsO45 VSV-G were obtained from J. Rose (Yale University, New Haven, CT) and C. Machamer (Johns Hopkins University, Baltimore, MD).
Transfection Procedure
HeLa cells were plated (5 x 105/35 mm dish) on the day before transfection. The cells were first washed two times with DME, then infected with a vaccinia T7 RNA polymerase recombinant virus (vTF7-3) (Fuerst et al., 1986) , at a multiplicity of 10 PFU/cell for 30 win with intermittent rocking in a 37~ incubator. The inoculum was removed and the cells cotransfected with 5 #g pET-tab plasmid DNA encoding for a mutated rab protein as described above, and 5 #g of plasmid encoding for VSV-G protein OAR-G) that had been premixed for 15 rain at room temperature in 1 ml DME and 15/tl of the transfection reagent (TransfectACE [Gibco-BRL]) as outlined by Rose (Rose et al., 1991) . 3 h post-transfection, an equal volume of DME/10% FBS was added to the cells and incubated for an additional 3 h to allow synthesis of VSV-G protein and the mutant tab protein. After the transfection period, the media was removed and the cells incubated for 15 win in methionine free MEM (Gibeo-BRL), biosynthetically labeled for 10 win with 20/zCi tmns [35S]-labe1 (spec. act. 1192 Ci/mmol, ICN Biomedicals, Inc., Irvine, CA), then chased for 1 h in DME/10% FBS. The chase was terminated by the addition of lysis buffer (50 mM Tris, pH 8.0, 150 mid NaCI, 1% Triton X-100, 1 mM PMSF) (Sigma Chemical Co., St. Louis, MO) and the lysate precleared for 30 min. with 50 ~1 Pansorbin (Calbiochem Corp., San Diego, CA). The soluble fraction was incubated overnight at 4~ with a monoclonal antibody to VSV-G (clone 8G5) and pansorbin. Immune precipitates were washed three times with 10 mM Tris, pH 6.8/1% SDS, befled, then centrifuged. To the supernatant was added 30 ~1 of 0.2 M citrate, pH 5.5 and 5/~1 of endoglycosidase H (endo H) (1 U/ml, Bovhringer Mannhelm Corp., Indianapolis, IN) and the sample digested overnight at 370C. Samples were analyzed by SDS-PAGE on 6.75% gels according to the method ofLaenunli (Laemmli, 1970) . The gel was soaked in 1 M salicylate/30% methanol for 30 rain, dried, then exposed to XAR-5 film (Eastman Kodak Corp., Rochester, NY) at -80~ Qnantitation of the VSV-G protein was accomplished using densitometxy as described previously (Beckers et al., 1987; Beckers and Balch, 1989; Schwaninger et ai., 1991) .
Transport Kinetics and Protein Expression of rablbu~1
HeLa ceils (3 x 106/10 cm dish) were infected/transfected at a multiplicity of 10 PFU/Cell and 30/~g of mutant rab and 30 #g pAR-G, as described above. 2 h post-transfection, the media was removed and saved, and the cells detached from the culture dish with PBS/50 mM EDTA. The cells were washed one time with DME then replated at equal number in 35-ram dishes with transfection media from the parental dish and equal volume of DME/10% FBS. This would allow a common pool of transfected cells to be analyzed. At 3, 4, 5 and 6 h post-transfection cells were biosynthetically labeled for 10 win and chased for 60 win in complete media, as outlined above.
To determine the level of expression of the rub protein, a comparable number of cells at each time point were detached from the dish with PBS/EDTA and washed one time with 10/18 (10 mM KOAc/18 mM HEPES [pH 7.2]). The cells were resnspended in 10/18 containing protease inhibitots (10 #g/ml leupeptin, 10 #l/ml aprotinin, 10 #M TLCK, 1 #g/wi chymotrypsin, 0.1 t~M pepstatin), swollen on ice for 10 win., then homogenized by 10 passes through a 23 gauge needle after which the concentration was adjusted to 25 mM KOAc/125 mM Hepes. The nuclei were removed by centrifugation for 5 rain. at 3,000 RPM and the post-nuclear supernatant centrifuged at 30 PSI for 30 rain. at 4~ in a Beckman Airfoge. The supernatant was removed and the membrane pellet resuspended in 25/125. Protein determinations were made by the Micro BCA Protein Assay Reagent (Pierce Chem. Co., Rockford, IL). Aliquots of the supernatant and membrane fractions (100 #g total protein) were separated by SDS-PAGE on a 12% gel and transferred to nitrocellulose (Schleicher and Schuell, Keene, NH) in 25 mM Tris pH 8.3, 192 mM glycine, 20% methanol. The membrane was blocked in 5 % nonfat dry milk, 0.05 % Tween-20 in TBS. Detection of rablb was with the polyclonal antibody p68 (Plutner et al., 1991) followed by I/~Ci 1251 Protein A (spec. act 85.6 t~Ci//zg, ICN). Standard curve was generated from purified recombinant rab protein.
Western Analysis of V~ld Type and
Mutant Rab Proteins
HeLa cells (5 x 105/35 mm dish) were infected/transfected, as outlined above. 6 h post-transfection, the cells were detached from the culture dish with PBS/EDTA, washed two times with PBS, then tysed in 10% ~.A for 2 h on ice. "ICA-precipitated material from the cells was washed one time with acetone and dissolved in 100 ~1 of sample buffer (0.1% SDS, 0.5 M Tris-HCI, pH 6.8, 10% glycerol, 5% B-mercaptoethanol, and 0.1% bromphenol blue). Samples were separated by SDS-PAGE using 12% gels and transferred to nitrocellulose as described above. After blocking, the membrane was incubated with the appropriate anti-rab antibody, washed then incubated with an alkaline phosphatase-conjugated second antibody (Pierce Chemical Co.) and developed with 5-bromo-4-chloro-3-indoyl phosphate and nitroblue tetrazolium (Pierce Chemical Co.). HeLa cell (5 x 105) lysate of non-transfected cells was coanalyzed to determine the endogenous level of rab protein. Purified recombinant rab proteins were included as controls. Overexpression of rab proteins was detected by antibody reagents specific for rablb (mSC6b) (Plutner et al., 1991) , rab2 CW. E. Balch, unpublished data), tab5 (generously provided by M. Zerial, EMBL) and a polyclonal antibody which cross-reacts with rabla, lb, 3 and 6.
Indirect Immunofluorescence
Hela cells (5 x 105) were plated on coverslips in 35-mm tissue culture dishes on the day before transfection. Cells were infected/co-transfected as above with 5/~g pAR tsO45-G, 5/~g pET rablb and/or 5/~g of pET rablbulb Cells were incubated at 40~ for 4 h followed by incubation at 32~ for 2 h. To terminate transport, the cells were transferred to ice, fixed in 2 % paraformaldehyde/PBS for 10 rain at room temperature. Fixation was quenched with 10 mM ammonium chloride in PBS for 10 win then blocked in PBS/5 % normal goat serum (NGS) for 10 rain at room temperature. To detect intracellular VSV-G, cells were permeabilized with 0.05 % saponin in PBS/NGS for 10 win, washed with PBS, then incubated for 30 win with a monoclonal antibody specific for the VSV-G protein cytoplasmic tail (P5D4). Cells were washed, costained for 30 rnin with Texas Red goat a-mouse antibody (Molecular Probes, Inc., Eugene, OR) and 10/~g/ml FITC-conjugated Lens culinaris lectin (E-Y Laboratories, San Mateo, CA) in PBS/NGS to label Golgi compartments containing terminal N-acetylglucosamine. For cell surface labeling, VSV-G was detected by an antibody specific for the extra-cellular domain of VSV-G (clone 8AG) followed by a Texas red secondary reagent, as described above. Coverslips were mounted in Moviol (Calbiochem Corp., San Diego, CA) and viewed under a Zeiss Axiovert fluorescence microscope.
Results
A Transient Expression System to Study rab Protein Function In lqvo
To study the in vivo consequences of mutated forms of the rub proteins on vesicular traffic, we employed a transient expression system in which HeLa cells are first infected with vaccinia T7 RNA polymerase recombinant virus (vTF7-3) then cotransfected with a mutant rab plasmid DNA and a plasmid encoding for vesicular stomatitis virus glycoprotein (VSV-G) (pAR-G) which serves as the reporter molecule (Fuerst et al., 1986; Moss, 1989) . VSV-G protein is a type I integral membrane protein which acquires two N-linked oligosaccharides during cotranslational insertion into the ER. Transport of VSV-G protein from the ER to the cis/ medial Golgi compartments results in processing of the high mannose (mang) endoglycosidase H sensitive (endo Hs) oligosaccharides found in the ER to the complex, endo H resistant (endo HR) forms present in the Golgi stack and on the plasma membrane due to trimming by Golgi associated mannosidases and glycosyl transferases. Appearance of the various oligosaccharide processing intermediates can be used to follow the transport of VSV-G through the cis, medial, and trans Golgi compartments. These intermediate forms of VSV-G can be distinguished by their unique mobilities after SDS-PAGE .
To establish conditions to study transport, Hela cells infected with vTF7-3 were transfected with the VSV-G protein encoding plasmid at 60 min intervals, biosynthetically radiolabeled for 10 min, then chased for 1 h in the absence of radiolabel. Immunoprecipitated G protein was first detected 3 h post-transfection and continued to increase in concentration in a linear fashion with time (data not shown). We selected the 4-6 h post-transfection period to study transport because both rab and VSV-G proteins were expressed at significant levels without adversely affecting the secretory pathway. The rate of transport of VSV-G from the ER to the Golgi complex in vaccinia infected cells transfected with the VSV-G plasmid after 5 h post-transfection is shown in Fig. 1 . For each time point, immunoprecipitated VSV-G protein was digested with endo H, then analyzed by SDS-PAGE and fluorography to determine the extent of VSV-G processing from the endo Hs to the endo HR form. As shown in Fig. 1 , the appearance of the endo HR form of VSV-G, coincident with transport to the cis/mediai Golgi compartments, occurred with a half time of ,~ 30 min. VSV-G protein was quantitatively (90%) converted to the endo HR form after a 60-75 min chase period (Fig. 1) . The efficiency of transport in different experiments was found to vary from 70-90%. The kinetics of VSV-G transport were identical to those observed in the presence of rifampicin or hydroxyurea, reagents which inhibit maturation of vaccirtia particles (Vos and Stunnenberg, 1988; Moss et al., 1991) . Figure 1 . Kinetics of transport of VSV-G from the ER to the Golgi complex in vaccinia infected/transfected HeLa cells. Vaccinia infection and pAR-G (a plasmid encoding the VSV-G protein) transfection were performed as described in Materials and Methods. 6 h post-transfection, cells were biosynthetically labeled with trans (35S) for 10 min, then chased for the indicated time in radioactive free media. VSV-G protein was immunoprecipitated and incubated in the absence (-) or presence (+) of endoglycosidase H (endo H) as described in Materials and Methods. The endoglycosidase sensitive (endo Hs, lower band) forms and endoglycosidase H resistant (endo Ha, upper band) form were separated by SDS-PAGE. The fraction (%) of VSV-G protein transported to the endo H resistant form (lower panel) was quantitated as described in Materials and Methods. VSV-G protein is converted to the endo HR form with a half-time of 30 min.
Mutations in GTP-Binding Domains of rub1 are Trans Dominant Inhibitors of ER to Golgi Transport
To identify rub proteins essential for vesicular transport between the ER and the Golgi complex, we performed sitedirected mutagenesis within domains involved in guanine nucleotide interactions. Ras and rab proteins contain four highly conserved GTP-binding domains Valencia et al., 1991) . Mutational and structural analysis of the ras protein have determined essential amino acid residues in these domains for binding and hydrolysis of GTP (reviewed in Barbacid, 1987; Valencia et al., 1991) (Table 1) . Amino acid substitutions at specific sites in the guanine nucleotide binding domains of ras alter guanine nucleotide binding affinity for GDP and GTP ( 
Phospho~l-Eff~tor domain Phospho~l-Guanine ring P~nyl~ion bi~ing si~ binding site contact site si~ * The amino acid sequences of rab-related proteins which make up the functional GTP-binding and effector domains are compared to H-ras (human). The numbering is that of H-rus. The functional designations are based on the crystal structure of ras. Mutations used in this study which alter GTP-binding or hydrolysis for ras are indicated by the asterisk although essentially mutations at all positions in these domains alter GTP-binding or hydrolysis (see Valencia et al., 1991 for review).
N~I ) (Der et al., 1988; Feig and Cooper, 1988) , abolish interaction with GTPase activating protein (GAP) ( Table 2 , 35 T~A ) (Haubruck and McCormick, 1991) and impair GTP hydrolytic activity (Table 1 , 12 G -' S , 61 Q~L ) (Haubruck and McCormick, 1991) . The prominent effects of these mutations on ras biological function and the conservation of these domains among all ras related proteins (Bourne et ai., 1991; Valencia et al., 1991) , suggest that these regions are likely to contain key residues critical for rab function. To study the in vivo effect of overexpression of mutant forms of rab proteins on vesicular transport, vTF7-3 infected HeLa cells were cotransfected with a rat) mutant and the VSV-G expression constructs for 5-6 h, pulse-labeled for 10 min, then chased for 1 h in nonradioactive medium to promote transport to the Golgi complex. The first mutation we generated in rablb and rabla was a substitution of N to I at position 121. The main function of this highly conserved ASN is to hold together the three elements which are involved in guanine nucleotide binding. In the case of ras, mutations in the consensus guanine nucleotide binding sequence NKXD (Table 1 , ras residues 116-119) have reduced guanine nucleotide binding affinity. As a consequence of enhanced GDP/GTP exchange, rash61 is a constitutively activated, transforming protein. The N to I substitution in the corresponding NKXD motif of both YPT1 and SEC4 result in mutant proteins which do not bind GTP and produce dominant lethal phenotypes and secretory defects when expressed in yeast Schmitt et al., 1988; Walworth et al., 1989) .
As shown in Fig. 2 , overexpression of rablbn. (~10-fold)
Table II. Summary and Properties of Rab Mutant Proteins
Asn ( trans dominant inhibitors of transport from the ER to the Golgi complex. Vaccinia infection and cotransfection protocols with pAR-G and mutant (pET) plasmids were as described in Materials and Methods. Briefly, 5 h post-transfection cells were labeled with trans (3~S) for 10 rain and chased for 60 rain in the absence of radiolabel. VSV-G protein was immunoprecipitated and digested in the absence ( -) or presence (+) of endo H, and the endo H sensitive (S) or resistant (R~ and R2) forms analyzed by SDS-PAGE as described in Materials and Methods. R~ is a processing intermediate with one of the two oligosaccharide chains processed to the endo H resistant form . R2 is the form of VSV-G containing two endo H resistant oligosaccharides fully processed and containing sialic acid. Transport of VSV-G protein from the ER to the Golgi complex is totally inhibited in cells overexpressing rablbl21i, and rabla12tl, and rablb22s.
resulted in a complete block of VSV-G protein transport (Fig. 2, lane l) . No processing of VSV-G protein to endo Ha forms was observed after the 60 min chase period compared to the control in which 75 % of the VSV-G protein was processed to the endo H resistant form (Fig. 2 , compare lanes b and l). VSV-G neither accumulated in the Man5 endoglycosidase D sensitive form (data not shown), a processing reaction diagnostic of protein transport to the cis Golgi compartment in the mutant CHO cell line clone 15B (Beckers et al., 1987) , nor in an early endo HR processing intermediate observed in the control (RI in Fig. 2 , lanes b or d) diagnostic of transport from the ER to the cis Golgi compartment in wild-type CHO cells . Identical results were obtained for rablam~ (95% identity with rablb) (Fig. 2, lane j) . As expected, recombinant rabla~2H (data not shown) or rablb~2~t did not bind detectable levels of GTP (<0.1%) compared to the wild-type proteins measured in solution or by Western blotting (Fig.  3, lanes a and e) . In contrast, VSV-G protein was efficiently (>85 %) transported and processed to the fully sialylated, complex form (R2 in Fig. 2 , lane d) in the presence of overexpressed (~10-fold) wild-type rablb or wild-type rabla (data not shown). We have been unable to detect any statistically significant change in the extent or rate of processing of VSV-G to endo Ha forms in cells overexpressing (10-fold) wild-type rabla or lb (data not shown), suggesting that the endogenous rabl protein is not rate limiting for transport of VSV-G protein from the ER to the terminal compartments of the Golgi complex.
To provide evidence that expression of the rablbm~ protein imposes a transport block between the ER and the Golgi stack, we analyzed the distribution of VSV-G in the presence of rablb~2, by indirect immunofluorescence. For this pur-' pose, Hela cells were transfected with a plasmid (pAR-tsO45-G protein) expressing a temperature-sensitive form of VSV-G which misfolds at the restrictive temperature (39.5~ and fails to be exported from the ER (Lafay, 1974; Balch et al., 1986) (Fig. 4, A [VSV-G] and B [Golgi complex]). TsO45-VSV-G is rapidly mobilized to the Golgi membranes when shifted to the permissive temperature (32~ (Fig. 4, C [VSV-G] and D [Golgi complex]). When cells cotransfected with pAR-tsO45-G and wild-type rablb and were held at the restrictive temperature for 4 h followed by a 90 min chase at the permissive temperature, VSV-G protein was found to be efficiently transported to the Golgi complex (Fig. 4 , E, E' [VSV-G] and F, F' [Golgi complex]). In contrast, expression of rablbmi resulted in the inability of VSV-G to enter the Golgi stack. The tsO45-G protein was partially transported to punctate structures scattered throughout the cytoplasm (Fig. 4, G, G' [VSV-G] and H, H' [Golgi complex]), similar to the distribution of pre-Golgi intermediates in BHK cells (Saraste, 1984; Saraste et al., 1991) . Furthermore, cells expressing tsO45 VSV-G and rablb~2u failed to transport VSV-G protein to the surface (Fig. 5, B) indicative of a block in transport.
The striking inhibition of protein transport produced by expression of rablb12H prompted us to examine the threshold of this mutated protein required to inhibit vesicular traffic. Cells cotransfected with the VSV-G protein encoding plasmid and pET rablb~2~, were radiolabeled at 3, 4, 5, and 6 h post-transfection for 10 min, chased for 1 h, then transport assessed as described above. In addition, the level of ex- pression and distribution of rablb between membrane and cytosol was quantitated by Western blotting (Fig. 6) . The endogenous pool of rablb in Hela cells is distributed between membrane-associated and soluble forms (Fig. 6, B) . Expression of rablb12~ after a 3 h post-transfection period resulted in •2 fold increase in the total rab pool (Fig. 5, B) . Even at this level of expression of the mutant protein, VSV-G protein transport to the Golgi complex was reduced by *25 % (Fig. 5, A) . From 4 to 6 h post-transfection, a 5-to 10-fold increase in rablbm~ was observed with rablbm, now being detected increasingly in the membrane fraction (Fig. 3, B) . At 6 h post-transfection transport was inhibited >80% (Fig.  5, A) . In general, overexpression of rablbm~ in the range of four to eightfold results in the total arrest of VSV-G protein transport and processing to the endo Ha form as early as 3-4 h post-transfection. We have been unable to reverse inhibition by cotransfection with pET wild-type rablb suggesting that the rablb12~ mutant irreversibly inhibits transport (data not shown). F/gum 4. Rablbm~ inhibits transport to the Golgi complex. Vaccinia infected cells (see Materials and Methods) were transfected with rablb or rablbmt cDNA, and a plasmid expressing the temperature-sensitive mutant form of VSV-G protein (pAR-tsO45-G) for 4 h at 39.5"C to retain tsO45 VSV-G in the ER. 4 h post-transfection, cells were shifted to the permissive temperature (32~ and incubated for 2 h. Cells were fixed, permeabilized, and the distribution of tsO45 and VSV-G protein (A, C, E, E', G, G5 and Golgi membranes (B, D, F,, F', H, H') viewed by immunofluorescence microscopy as described in the Materials and Methods, (A, B) Distribution of tsO45
VSV-G (A) or Golgi membranes (B) after 6 h continuous incubation at 39.5~ (C, D) Distribution of tsO45 VSV-G (C) or Golgi membranes (D) after incubation for 2 h at 320C. (E, F) Distribution of tsO45 VSV-G (E, E') or Golgi membranes (F,, F') after incubation for 2 h at 32"C in the presence of rablb protein. (G, H) Distribution of tsO45 VSV-G (G, G') or Golgi membranes (H, H') after incubation
for 2 h at 32~ in the presence of rablbm~ protein.
To further characterize the role of GTP-binding in the regulation of rabl function in ER to Golgi traffic, mutations were generated in two domains involved in either interaction with the phosphates or the guanine ring (Table 1) . Rablb22N (Table 2 ) is equivalent to the raslTN mutation which exhibits a 20-fold reduced affinity for GTP but not GDP. It is thought that raslTN is locked in the GDP-bound form and to be associated constitutively with a ras guanine nucleotide dissociation stimulator (GDS) (Feig and Cooper, 1988) . This mutant is a potent inhibitor of mammalian cell proliferation and believed to antagonize normal ras function by competition for GDS. As shown in Fig. 2 Oane f ) , expression of rablb22N ("ol0-fold) above the endogenous pool of rablb (data not shown) potently inhibited transport resulting in <2% of VSV-G processed to the endo FIR forms. In contrast, overexpression of rablb67L (Table 2) , which in ras (ras61L) eliminates the intrinsic and GAP-stimulated GTPase activities (Haubruck and McCormick, 1991) , did not inhibit transport (Fig. 2, (ctl) shows the level of endogenous rablb. (C) The standard curve for rablb concentration was generated using purified recombinant rablb. Figure 5 . VSV-G protein is not delivered to the cell surface in HeLa cells expressing rablb12u. Vaccinia infected cells (see Materials and Methods) were transfected with a plasmid expressing the temperature-sensitive mutant form of VSV-G protein (pAR-tsO45-G) in the absence (,4) or presence (B) of the plasmid expressing rablbml for 4 h at 39.50C. After 4 h, cells were shifted to the permissive temperature (32~ and incubated for 2 h. Cells were fixed and surface expression of tsO45 VSV-G protein determined by indirect immunofluoresccncr using an antibody specific for the extracellular domain of VSV-G as described in Materials and Methods.
Golgi to the cell surface in yeast (Walworth et al., 1989) . As expected, rablb:2N did not bind GTP after Western blotting whereas rablb~TL GTP-binding was normal (Fig, 3, compare  lanes b and d) .
Rablbuu Lacking the Carboxyl-terminal CC Motif Is a Trans Dominant Inhibitor of Transport
Prenylation of the carboxyl-terminal cysteine residues of small GTP-binding proteins is required for membrane association and function (reviewed in Der and Cox, 1991) (Table 1) . We have previously demonstrated that the carboxyl-terminal CC residues of rablb are post-translationally modified by a geranylgeranyl isoprenoid (Khosravi-Far et al., 1991) . To assess the importance of this modification in rablb function, truncation (ACC) mutants were generated from the wild-type rablb and mutant rablbm~ proteins. As shown in Fig. 7 , deletion of the terminal CC residues from the wild-type protein had no effect on transport. VSV-G protein was efficiently processed to the endo Ha form (Fig. 7 , lane d, 65 % endo Ha). Rablb~cc bound GTP at levels comparable to the wild-type protein (not shown). In contrast, and to our surprise, the rablb~2~], ~cc mutant inhibited ER to Golgi transport as efficiently as the nontruncated mutant (Fig. 6 , lane f, <1% endo Ha) suggesting that a nonprenylated form of the mutant can effectively interfere with some aspect of the transport machinery governing rabl function.
To determine whether additional sequence information in the carboxyl-terminus of rablb was necessary to yield the trans dominant phenotype produced by the rablbmi mutant, we replaced the COOH-terminal 35 amino acids of rablbt2, with the carboxyl-terminal 35 amino acids of rab5 to generate the hybrid construct rablb~Hs0)t2~drab5,6~-~89) ( Table 2 ). The carboxyl-terminus of rab5 has been suggested to encode key information dictating the localization of the rab5 protein to an early endosome compartment (Chavrier et al., 1991) . This mutant chimera binds GTP indicating that it folds properly to form a native structure (data not shown). In contrast to rablbm~, ~cc, overexpression (*10-fold) of the hybrid (data not shown) had no effect on VSV-G transport (Fig. 7) .
Rabl Effector Domain Mutations
Mutations in amino acids 32-40 of ras (the effector domain [ Table 1 ]) do not, for the most part, alter the intrinsic properties of ras yet abolish transforming activity of the oncogenic forms (Hall, 1990; Haubruck and McCormick, 1991) . Mutations in this region which destroy ras transforming activity typically eliminate the ability of GAP to bind efficiently to ras. Although the ras and rab effector domains are highly divergent, the 35T residue within the ras effector domain is invariant among all ras and ras-related proteins (Table 1) (Velencia et al., 1991; Wittinghofer and Pai, 1991) . Substitution of 35T with A results in loss of ras transforming activity and prevents GAP stimulation of GTPase activity.
To determine whether mutations in the rablb effector domain would inhibit ER to Golgi transport, three different mutants were generated (Table 2) : rablb40A, rablb4~M and rablb**s. In the case of rablb4~M GTP-binding is comparable to the wild-type protein (Fig. 3, lane c) . Rablb4tM and rablb**N are identical to YPTIp effector domain mutants recently reported to yield secretory defects in ER to Golgi transport in yeast (Becket et al., 1991) . As shown in Fig. 8 , we have detected weak, yet reproducible inhibition with rablb4~M (Fig. 8, 50% endo Ha). This mutation in YFEp yields the strongest trans dominant phenotype (Becker et al., 1991) . In contrast, no inhibition was observed by overexpression of the rablb40^ or rablb~N (Fig. 8) . Because the 44N substitution in YPT1 results in a temperature sensitivephenotype (Becker et al., 1991) we tested whether a block in transport could be detected at an elevated temperature (39.5~ in the presence of the rablboN protein. As before, no inhibitory phenotype was detected (data not shown). In all cases, expression levels were ,,ol0-fold that of the endogenous pool (data not shown). These results are compatible with the observation that effector domain mutations in mammarian ras are generally neither trans dominant nor growth inhibitory (Hall, 1990; Haubruck and McCormick, 1991) .
Mutations in the GTP-Binding Domains of rab2 are Trans Dominant Inhibitors of ER to Golgi Transport
The tab2 protein, which is highly divergent from rablb (<40% identity), has been immunolocalized to the tubularvesicular compartments believed to function in ER to Golgi transport (Chavrier et al., 1990a) . However, no genetic or biochemical evidence is currently available which demonstrates its involvement in vesicular traffic.
To determine if rab2 functions in ER to Golgi transport, rab2 mutants were generated based on our observations for the rablb constructs (Table 2) . We first tested rab2,9~ (equivalent to rablbm~), a mutant which was likely to yield a trans dominant inhibitory phenotype. Rab2Hg~ failed to bind GTP on Western blots (Fig. 3, lane j) and strongly inhibited protein transport from the ER to the Golgi complex (Fig. 9, <5 % endo H resistant). In contrast, expression of rab2 wild-type protein neither stimulated nor inhibited the transport of VSV-G protein to the Golgi (Fig. 9 , 65 % endo HR). Three additional mutants were generated (Table 2) : 1) rab220N, analogous to the rasl7N mutation, 2) rab238A, an effector domain mutation, and 3) rab265L corresponding to the oncogenic ras61L mutation. We observed (Fig. 2, lane f ) only a partial inhibition in membrane traffic by rab220N (Fig. 9 , 45% endo Ha), although it was expressed as efficiently as rabl proteins (~10-fold) and did not bind GTP after Western blotting (Fig. 3, lane g) . Surprisingly, the rab265L mutant was a potent inhibitor of transport (Fig. 9 , <1% endo Ha) and bound GTP at levels comparable to wild-type (Fig. 3, lane i) . The equivalent rablb67L had no effect on transport (Fig. 2, lane h) . We have also consistently detected a weak, but reproducible inhibitory phenotype with the rab238A effector domain mutation (Fig. 9, 40% endo Ha). As expected, GTP-binding by this mutant was comparable to wild type (Fig. 3, lanes f and h) . The combined results suggest not only that rab2 is critical for ER to Golgi traffic, but the biochemical interactions facilitating rab2 function differ from those for rablb.
Overexpression of rab3a, rab5, rab6 Wild Type and GTP-Binding NKXD Mutant Proteins Have No Effect on Vesicular Traffic Between the ER and the Golgi Complex
To show that VSV-G protein transport inhibition between the ER and Golgi compartments is specific to those rab mutants described above, we expressed rab proteins which have been reported to participate in other steps of vesicular transport. To this end, we introduced the equivalent rasH~ mutation in rab3a, rab5, and rab6. Rab3 is involved in regulated exocytosis in endocrine, exocrine, and neural tissues and has been Figure I0 . Substitution of 116I (ras numbering) in the GTP-binding domains of rab3a, rab5, and ras does not inhibit VSV-G protein transport from the ER to the Golgi complex when expressed in Hela cells. Infection/transfection conditions and analyses were as described in Materials and Methods. localized to exocytic vesicles (Darchen et al., 1990; Fisher von Mollard et al., 1990) . Rab5 has been localized to endosomal compartments and is involved in early endosome fusion in vitro (Chavrier et al., 1991; Gorvel et al., 1991) . The rab6 protein has been localized to the medial-trans compartments of the Golgi complex . As indicated in Fig. 10, overexpression (•10-fold) of the wildtype or mutant rab3a~3m wild-type or mutant rab5~3~, or H-rasH61 had no statistically significant inhibitory or stimulatory effect on processing of VSV-G protein to the endo Ha form. In addition, we have been unable to detect any inhibitory effect of overexpression of rab6~26~ on processing of VSV-G to the terminally sialylated, complex form (Fig. 11) . Given that sialyltransferase is a late-processing enzyme predominantly found in the trans Golgi compartment and trans Golgi network, these results suggest that rab6 is not essential for transport between cis, medial or trans Golgi compartments. Similarly, the inability of H-ras, rab3a, rab5 and rab6 NKXD mutant proteins to inhibit VSV-G transport between the ER and the Golgi complex indicates that these proteins do not interact with the biochemical machinery g~'erning rabl or rab2 function.
Discussion
Disruption of ER to Golgi Transport by rabl and rab2
Mutations Affecting GTP Binding and Hydrolysis
Mutational analysis of ras and ras-related proteins has re- Figure 11 . Expression of rab6n~ does not inhibit VSV-G protein transport from the ER to the Golgi complex. Infection/transfection conditions and analyses were as in Materials and Methods. vealed critical residues within conserved domains involved in GTP binding, exchange and hydrolysis required for function. We have used the structure/function data reported for the ras protein as our prototype to map functional domains in the rab proteins necessary for vesicular traffic from the ER to the Golgi complex.
Since guanine nucleotide binding regulates the biological activity of ras, we generated the N to I substitution in the consensus NKXD (ras residues 116-119) GTP-binding domain present in all ras-related proteins. While this substitution activates ras transforming potential (Der et al., 1988) , analogous mutants of YPT1 Schmitt et al., 1988) , SEC4 (Walworth et al., 1989) , and rab5 (Gorvel et al., 1991) exhibit trans dominant inhibitory phenotypes. To identify trans dominant inhibitors of ER to Golgi transport we made use of the T7 RNA polymerase produced by recombinant vaccinia virus to direct high level transient expression of rab proteins and VSV-G protein. In this system, rablb~2H was a potent inhibitor of VSV-G protein transport from the ER to the Golgi complex based on the observation that the two N-linked oligosaccharides of VSV-G protein failed to be processed to early post-ER, cis Golgi forms . Indirect immunofluorescence studies confirmed the biochemical results: VSV-G failed to enter the Golgi stack and was not detected on the cell surface. Thus, it is unlikely that the inability to trim VSV-G protein oligosaccharides to endo Ha forms is due to a processing defect per se or an "end-run" around the Golgi complex. The punctate intermediates in which VSV-G accumulated in the presence of the rablbnH mutant was strikingly similar to the distribution of a putative pre-Golgi intermediate compartment postulated to be involved in ER to Golgi transport (Saraste and Kuismanen, 1984; Saraste and Svensson, 1991; Schweizer et al., 1988) . Although the data presented here does not directly distinguish between accumulation of VSV-G protein in a terminal export site (budding vesicle) associated with the ER network or accumulation in a downstream post-ER, pre-Golgi transport intermediate, our preliminary analysis using immunoelectron microscopy strongly suggests the latter interpretation (W. E. Balch and M. G. Farquhar, unpublished data) . The identification of the intracellular compartment where transport is blocked by other trans dominant negative mutations is currently under investigation.
Overexpression of rablanH yielded an identical biochemical phenotype to that observed for rablbml. Rabla and rablb are 95 % identical, with the major differences being found in both conservative and nonconservative substitutions in the carboxyl-terminus (Zahraoui et al., 1989) . Given the ability of mouse rabla to substitute for YPTlp in yeast (Haubruck et al., 1989) , our results suggest that rabla and rablb proteins may be functionally interchangeable in mammalian cells. Redundancy in expression of highly-related isotypes is not unusual among members of the ras-superfamily of small GTP-binding proteins (Valencia et al., 1991) .
Biochemical and mutational analyses of rab-retated proteins found in the exocytic pathway of yeast (Schmitt et al., 1988; Bacon et al., 1989; Walworth et al., 1989; Baker et al., 1990; Kaiser and Schekman, 1990; Becker et al., 1991; Rexach and Schekman, 1991) supports our interpretation that rabl is essential for ER to Golgi transport. Specifically, YPTlI2n and SEC4133~ do not bind GTP and are dominantlethal mutants (Salminen and Novick, 1987; Walworth et al., 1989) . Although the morphological and biochemical phenotype of YPTlnl~ in the secretory pathway of yeast has not been examined, temperature-sensitive mutants of YPT1 accumulate invertase and carboxypeptidase Y in the coreglycosylated pre-Golgi oligosaccharide forms, and accumulate ER and pre-Golgi transport vesicles in vivo and in vitro (Schmitt et al., 1988; Segev et al., 1988; Bacon et al., 1989; Walworth et al., 1989; Baker et al., 1990; Kaiser and Schekman, 1990; Becker et al., 1991) . Likewise, SEC4133r leads to the accumulation of transport vesicles between the trans Golgi compartment and the cell surface (Walworth et al., 1989) . These data support our biochemical observations and morphological studies suggesting that rablbnH expression results in the accumulation of VSV-G protein in pre-Golgi compartments. However, unlike the reversal of the dominant lethal phenotype observed by overexpression of wild-type protein on the negative effects of SEC41221 and YPT11211 in yeast (Schmitt et al., 1988; Walworth et al., 1989) , overexpression of rablb wild type was unable to compete with rablb12tl. We suggest that rablb1211 may inhibit transport by an irreversible binding to an effector molecule(s) required for rablb function.
The 116I (ras numbering) mutation in the NKXD domain of rab3a, rab5, rab6, and H-ras did not inhibit transport between the ER and Golgi membranes, consistent with their lack of activity in the early compartments of the secretory pathway. Although rab6 has been localized to medial/trans compartments of the Golgi complex (Goud and McCaffrey, 1991) , overexpression of rab6126~ failed to inhibit processing of VSV-G to the complex sialic acid containing structure. Transport between the medial and trans Golgi compartments is likely to involve vesicular carriers . The inability of rab6~2~ to inhibit VSV-G transport suggests that rab6 does not regulate this step in the pathway. The combined results strengthen the general model that specific rab proteins participate in unique molecular interactions which regulate the function of different membrane-bound compartments in the endocytic and exocytic pathways. The analogous rasnt~ substitution in different rab proteins will likely serve as a general and sensitive tool to define the role of uncharacterized rab proteins in endomembrane function.
In addition to the requirement for rabl, we have provided the first evidence that rab2 is essential for transport from the ER to the Golgi complex. Our data supports the observation that rab2 is localized to pre-Golgi tubular-vesicular elements believed to be involved in ER to Golgi transport (Chavrier et al., 1990a; Saraste and Kuismanen, 1984; Saraste and Svensson, 1991; Schweizer et al., 1988) . The evolutionary divergence of rab2 from rabl (<40% identity [Valencia et al., 1991] ) suggests that a distinct collection of upstream and downstream effector proteins regulating guanine nucleotidebinding, hydrolysis and/or membrane-association exists for the rab2 protein. To date, a tab2 homologue has not been detected in yeast. Whether the mammalian and yeast pathways differ in this respect is not known.
Mutations in a second domain involved in GTP-binding (GXXXXGKS/T) were examined (Table 1, ras numbering 10-17). The 17N substitution in ras is thought to result in formarion of a GDP-complexed form (Feig and Cooper, 1988) due to the tight-binding of a ras specific GDS to this mutant protein. Because this protein is essential for normal ras func-tion, cells expressing this mutant are growth inhibited. While the rablb22N was a potent inhibitor of transport, the identical substitution in rab2 had a markedly reduced effect. We would propose that GDP/GTP exchange is critical for regulation of carrier vesicle function by rab 1. Although GDI and GDS proteins have now been identified for a number of rab and rab-related small GTP-binding proteins (reviewed in Takai et al., 1992) their role in transport and other cellular functions remains to be elucidated.
We also examined the function of the highly conserved DTAGZEX domain (Table 1 , ras numbering 5%63) which interacts with the phosphoryl group (Table 1 ). In the case of ras, this domain is critical for GTPase activity (Hall, 1990) and insures specificity to ras-GAP (Maruta et al., 1991) . RaSr~L mutants have impaired intrinsic and GAP-stimulated GTPase activities which favor formation of the active, GTPcomplexed form and results in transformation (Der et al., 1986) . Whereas rablb67L did not inhibit transport, rab2~L was a potent trans dominant inhibitor of VSV-G protein transport. The failure of rablb67L to arrest transport mirrors the observation that a similar mutation in SEC4 (SEC479L) has no effect on vesicular transport from the trans Golgi to the cell surface in yeast (Walworth et al., 1989) . In contrast, the inhibitory phenotype observed for rab2~L agrees with results reported for ras, suggesting that the inability to hydrolyze GTP or enhanced GAP-binding contributes significantly to transport inhibition. Why rabl and rab2 differ in this respect is unknown. It may simply reflect differing roles of the GDP versus GTP bound forms in protein traffic. In this regard, the models that have been proposed to provide a general interpretation for rab protein function are likely to be oversimplified (Bourne, 1988) . Clarification of these differences will require purification of the relevant proteins and characterization of their activities in vitro in the context of vesicular transport.
Mutations in the rabl and rab2 effector domains (Table 1 , residues 32--40 [ras numbering]) were generated to disrupt the interaction with putative downstream effector molecules. Although effector domain mutations in YPT1 show a strong trans dominant phenotype (Becker et al., 1991) and a marked reduction in GTPase stimulation by YPT1-GAP (Becker et al., 1991) , identical mutations in rabl or rab2 only partially inhibited transport. Mouse rabla can substitute for YPTIp function in yeast only when the protein is strongly overexpressed (Haubruck et al., 1989) . The combined results suggest that high levels of expression of rabla in null mutants lacking YPTI may be necessary to compensate for reduced affinity of rabla for yeast components rather than intrinsic stability.
Mutations in the Carboxyl-terminal Domain
Post-translational modifications of the carboxyl-terminal cysteine residues of ras and related small GTP-binding proteins are critical for function in vivo (reviewed in Maltese, 1990; Der and Cox, 1991) . Due to the importance of prenylation for function of ras and ras-related proteins, we anticipated that the CC truncation would eliminate the trans dominant inhibition produced by rablb~2t[ expression. Both the unprocessed (ACC) mutants of YPT~331 and SEC41331 in yeast (Schmitt et al., 1984; Walworth et al., 1989) , or unprocessed oncogenic RAS/ras mutants in yeast and mammalian cells lack trans dominant function . To our surprise the double mutant, rablb121~.acc remained a potent inhibitor of transport. A reasonable explanation is that lack of prenylation may lead to phenotypically distinct results for rab and ras-related proteins which reflect differences in their biochemical interactions. In the case of rablbmt, the unprenylated form may still participate in a subset of biochemical reactions characteristic of the wild-type protein. In support of this interpretation, at least 50% of the unprocessed form of rablb~2,.acc sediments with membranes (W. E. Balch, unpublished observations). In this case, the rablb12u mutant may irreversibly bind a critical component(s) essential for transport leading to inhibition.
To gain insight into the role of additional residues in the carboxyl terminus for rabl function, we generated the rablbm~/ rab5 chimera. At least 35 amino acids of the COOH-terminal tail of rab5 have recently been reported to be critical for localization of rab5 to the early endosome (Chavrier et al., 1991) . A rab2 chimera containing the carboxyl-terminus of tab5 is found in the early endosome (Chavrier et al., 1991) . Because the rablb~2H/rab5 chimera had no inhibitory effect on transport, our results indicate that the carboxyl-terminal tail of the rablb protein either contains essential sequence information facilitating its interaction with the biochemical machinery governing transport, or that mislocalization (i.e., the endosomal pathway) efficiently segregates the mutant from proteins involved in ER to Golgi trafficking.
Role of rab Proteins in Vesicular TraJficking Between the ER and Golgi Compartments
The mutational analysis of rab protein function is consistent with a number of biochemical probes we have developed to explore rabl protein function in vitro. Recently we demonstrated that transport between the ER and the Golgi complex in vitro can be inhibited by a monoclonal antibody specific for rablb (Plutner et al., 1991) . In the absence of rablb, VSV-G protein fails to exit the ER suggesting that rabl or rablbassociated proteins are essential for vesicle formation (Plutner et al., 1992) . Upon initiation of transport in vitro, VSV-G protein becomes rapidly transported to pre-Golgi intermediates enriched in rabl (Plutner et al., 1992; Schwaninger et al., 1992) . This rapid recruitment of rabl coupled to the observation that the GDP-bound form of the SEC4 protein is required for membrane association CKabcenell et al., 1990; Saski et al., 1991) suggests that the rablb22N mutant may inhibit transport by blocking the function of components involved in GDP/GTP exchange during an early step in vesicle formation. While the consequences of overexpression of the GDP-bound mutant form on cell morphology remain to be elucidated, an acti~tted form, such as the rablbm~ mutant may inhibit a later targeting or fusion step. This interpretation is supported by the observation that VSV-G protein accumulates in punctate vesicular structures which are reminiscent of pre-Golgi intermediates (Saraste and Svensson, 1991) in the presence of mutant protein in vivo, and in the presence of the rab3AL peptide in vitro (Schwaninger et al., 1992) . Moreover, it is consistent with the observation that similar activating mutations in SEC4 (Walworth et al., 1989) or YPT1 (Segev et al., 1988; Bacon et al., 1989; Baker et al., 1990; Kaiser and Schekman, 1990; Rexach and Schekman, 1991) result in the accumulation of intermediate transport vesicles in viva and in vitro. The role of rab2 in transport is unknown. However, the observation that endocytosis involves at least two rab proteins, rab4 and rab5 (Gorvel et al., 1991; van der Sluijs et al., 1991) suggests that multiple rab proteins may regulate sequential or competing biochemical interactions between intraceUular compartments.
Through examination of the biochemical and morphological consequences of expression of these and additional mutants on protein transport in viva and in vitro we hope to gain insight into the role of rabl and rab2 in ER to Golgi traffic.
